TP53 and cervical cancer: Among these markers, HPV status (especially HPV-16 and HPV-18), p16ink4a overexpression, TP53 mutations, and mTOR pathway activation are a few pertinent molecular signatures of cervical cancer that are associated with an aggressive disease with a poor prognosis [12].